GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

A programme looking to advance the understanding of how cancer develops has been backed with £50 million. Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford ...

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

A new cancer vaccine is being created to analyse how pre-cancerous cells develop to target the disease before it takes hold.

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers ...

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...